Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

ChromoTek Changes Distribution in the USA and Canada

Published: Monday, October 28, 2013
Last Updated: Sunday, October 27, 2013
Bookmark and Share
ChromoTek has changed its partner to Bulldog Bio Inc.

ChromoTek GmbH has changed its partner in the USA and Canada to Bulldog Bio Inc for its entire line of affinity reagents.

Bulldog Bio will now handle all sales and support of their extensive line of novel tools for protein and cell biology.

Chromotek’s nanobody-based reagents have opened the door to enhancing research with GFP and RFP fusion proteins, chromatin, cell cycle, and epigenetics analyses.

Bulldog Bio will focus its marketing effort to build a North American business with equal penetration as seen in the European market.

“Chromotek’s nanobody-based GFP-Trap, RFP-Trap, GFP-Booster and RFP-Booster affinity reagents have already been referenced more than 400 times in peer-reviewed publications. This is a testament as to the power of Chromotek’s products to make solid contributions to labs who utilize GFP- and RFP-fusion proteins in their research.”, Ella Fontaine further details “It is our goal, not only to provide the existing customers with better prices and faster service, but also spread the message that these reagents can help your research goals immediately.”

The terms of the distribution contract have not been disclosed.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Nippon Genetics and Bulldog Bio Create Alliance in North America
Bulldog Bio to sell many of Nippon Genetics’ electrophoresis and cell biology products.
Thursday, July 18, 2013
Eppendorf Licenses Thermal Cycler Technology to Bulldog Bio
License covers the GenePro and LifePro gradient thermal cycler models sold by Bulldog Bio.
Wednesday, September 07, 2011
Acqua Science Signs Bulldog Bio as Exclusive Partner in the USA
Partnership allows Bulldog Bio to exclusively represent Acqua Science’s new line of protein analytical tools.
Wednesday, June 29, 2011
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Scientists Find Lethal Vulnerability in Treatment-Resistant Lung Cancer
The study describes how the drug Selinexor killed lung cancer cells and shrank tumors in mice when used against cancers driven by the aggressive and difficult-to-treat KRAS cancer gene.
How Baby’s Genes Influence Birth Weight And Later Life Disease
The large-scale study could help to target new ways of preventing and treating these diseases.
Genes Underlying Dogs’ Social Ability Revealed
The social ability of dogs is affected by genes that also seem to influence human behaviour, according to a new study from Linköping University in Sweden.
‘Cellbots’ Chase Down Cancer, Deliver Drugs Directly to Tumors
Programmable T cells shown to be versatile, precise, and powerful in lab studies.
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
C Dots Show Powerful Tumor Killing Effect
Nanoparticles known as Cornell dots, or C dots, have shown great promise as a therapeutic tool in the detection and treatment of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!